Imatinib Mesylate in Treating Patients With Locally Advanced Gastrointestinal Stromal Tumor

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 28, 2005

Conditions
Gastrointestinal Stromal Tumor
Interventions
DRUG

imatinib mesylate

PROCEDURE

conventional surgery

PROCEDURE

neoadjuvant therapy

Trial Locations (9)

A-1090

Allgemeines Krankenhaus - Universitatskliniken, Vienna

D-13122

Robert Roessle Comprehensive Cancer Center - Charite Campus Buch, Berlin

D-53105

Universitaetsklinikum Bonn, Bonn

D-50924

Medizinische Universitaetsklinik I at the University of Cologne, Cologne

D-20246

University Medical Center Hamburg - Eppendorf, Hamburg

D-81377

Klinikum der Universitaet Muenchen - Grosshadern Campus, Munich

D-81675

Klinikum Rechts Der Isar - Technische Universitaet Muenchen, Munich

D-72076

Southwest German Cancer Center at Eberhard-Karls-University, Tübingen

D-65199

Dr. Horst-Schmidt-Kliniken, Wiesbaden

All Listed Sponsors
lead

Technical University of Munich

OTHER

NCT00112632 - Imatinib Mesylate in Treating Patients With Locally Advanced Gastrointestinal Stromal Tumor | Biotech Hunter | Biotech Hunter